Treatment of Rare Mutations in Patients with Lung Cancer

Lung cancer is a worldwide prevalent malignancy. This disease has a low survival rate due to diagnosis at a late stage challenged by the involvement of metastatic sites. Non-small-cell lung cancer (NSCLC) is presented in 85% of cases. The last decade has experienced substantial advancements in scien...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Tarek, Khoury, Rasha, Brenner, Ronen, Nasrallah, Haitam, Shofaniyeh, Irena, Yousef, Samih, Agbarya, Abed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151457/
https://www.ncbi.nlm.nih.gov/pubmed/34064757
http://dx.doi.org/10.3390/biomedicines9050534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151457/
https://www.ncbi.nlm.nih.gov/pubmed/34064757
http://dx.doi.org/10.3390/biomedicines9050534

Ejemplares similares